SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is drawing heavy community interest following an SEC filing that updated executive change-of-control agreements, which investors are interpreting as a signal that the company is positioning for an imminent buyout. This speculation is amplified by a high-pressure environment for shorts, characterized by surging borrow fees and constrained share availability, as traders prepare for the long-anticipated unblinding of the REGAL trial's 80th event.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors aggressively rotate capital out of software and hyperscaler names toward memory and chip sectors. The community remains deeply divided, with many expressing frustration over heavy capital expenditure and lack of price support, while contrarian investors argue the current valuation represents a rare, generational buying opportunity.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a focal point for retail investors, driven by a volatile mix of speculative short-squeeze theories, potential buyout rumors involving activist investors, and high trading volume. While the community is actively debating the stock's long-term value and dividend yield against aggressive institutional short-selling, retail sentiment remains deeply divided between those holding for a potential breakout and those warning of a classic pump-and-dump scenario.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing heightened volatility and selling pressure as investors scrutinize the company's decision to raise prices across its Mac and iPad lineups in response to surging memory and storage costs driven by AI data center demand. While some community members view the price hikes as a necessary margin-protection move that loyal consumers will absorb, others are concerned about demand elasticity and the broader implications for tech sector profit margins amid persistent inflationary headwinds.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as investors react to its direct correlation with Bitcoin's recent price decline and mounting fears regarding corporate dilution. The stock remains a primary battleground between bulls anticipating a long-term turnaround fueled by institutional adoption and bears focused on potential liquidity risks and structural concerns.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending following a blowout earnings report that shattered expectations and triggered a wave of aggressive analyst price target hikes. Investors are actively debating whether this performance marks a sustainable, long-term shift in the memory supercycle or if the rapid price increases are fueling unsustainable AI infrastructure inflation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is currently experiencing heightened volatility and significant volume spikes, driven by unconfirmed market chatter regarding a potential acquisition and speculative interest in biotech sector rotation. While some investors remain skeptical due to recurring historical price stagnation, others are betting on heavy upside through aggressive call option accumulation as the stock tests key resistance levels.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is trending following a new distribution agreement with NBCUniversal that restores key content, which the community sees as a long-awaited catalyst to reverse recent subscriber losses and volatility. Despite the news, investors remain deeply divided, with some betting on a turnaround fueled by major sports events, while others express intense frustration over historical share performance, management's compensation, and continued insider selling.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing significant selling pressure as part of a broader rotation out of high-multiple software stocks, fueling intense debate between retail investors bracing for a potential test of double-digit support levels and long-term believers who view the decline as a generational buying opportunity. Community sentiment is deeply polarized, with many traders actively discussing the stock's role in the AI infrastructure race versus concerns over its valuation, recent insider selling trends, and the ongoing influence of vocal short-sellers.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors react to a quarterly report featuring an earnings beat and upward revisions to full-year guidance, though the stock's price action remains contentious due to ongoing debates about the impact of the upcoming TDAPA reimbursement transition. The community is actively discussing management's execution, the potential for expanded product adoption, and frustration with stagnant share price movement despite strong operational performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RAPP phase 3 hasnt started, when it does, data wont come out until end of 2027 early 2028. Has this gotten ahead of itself?

StockTwits For Android 

Rapport Therapeutics Inc

 phase 3 hasnt started, when it does, data wont come out until end of 2027 early 2028. Has this gotten ahead of itself?

Shardlake

@MooseG possibly, but it has more legs than other shit biotechs. If you are not aware of recent news, here you go. IMO it seems promising, but I hold zero position in this. Good luck! 

“The January update suggests Rapport believes the Phase 2a results were strong enough to justify moving faster into later-stage testing. The AAN presentation is important because follow-up data can show whether the seizure reduction and tolerability hold up over a longer period. There was also a March deal with Tenacia Biotechnology giving it rights to develop and commercialize RAP-219 in greater China, which adds outside validation and potential non-dilutive funding.”

StockTwits for iOS

 possibly, but it has more legs than other shit biotechs. If you are not aware of recent news, here you go. IMO it seems promising, but I hold zero position in this. Good luck! 

“The January update suggests Rapport believes the Phase 2a results were strong enough to justify moving faster into later-stage testing. The AAN presentation is important because follow-up data can show whether the seizure reduction and tolerability hold up over a longer period. There was also a March deal with Tenacia Biotechnology giving it rights to develop and commercialize RAP-219 in greater China, which adds outside validation and potential non-dilutive funding.”